Cited by 89Reproductive Health and TechnologiesHealth Systems, Economic Evaluations, Quality of LifeAssisted Reproductive Technology and Twin Pregnancy

Economic aspects of infertility care: a challenge for researchers and clinicians: Figure 1

Open access
ESHRE Capri Workshop Group, ESHRE Capri Workshop Group, D.T. Baird, Pedro N. Barri, Siladitya Bhattacharya, P. Devroey, Johannes L.H. Evers, Luca Gianaroli +16 more·2015·Human Reproduction

Abstract

Infertility care has improved remarkably over the last few decades and has received growing attention from health care providers. Several treatments, including expensive options such as Assisted Reproductive Techniques, are now widely available for routine clinical use. In most cases, adoption of these treatments has occurred without robust cost-effective analyses. IVF for unexplained infertility and ICSI in the absence of semen abnormalities are two examples of this gradual technology creep. More in-depth economic analyses in the field of infertility are undoubtedly warranted. However, performing these analyses is challenging because infertility care poses a number of unique challenges. Studies of cost-effectiveness are open to criticism because there is a lack of consensus about the outcomes of choice and the appropriate perspective. The use of quality adjusted life years (QALYs) to allow comparisons with other clinical conditions is also controversial because the value associated with infertility care cannot be easily captured in QALYs. Moreover, their use triggers the crucial question of whose QALYs merit consideration-an individual's, a couple's or a child's. In conclusion, economic analysis in infertility represents a peculiar but crucial challenge. If management of infertility is to become an integral part of publicly or privately funded health care systems worldwide, better quality data and a shared vision about the costs and benefits of infertility treatments are needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/humrep/dev163

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fertility care is cost-effective and represents a positive return on public investment through the future economic value of babies resulting from fertility treatments.

    “Indeed, fertility care is cost-effective and represents a positive return on public investment through the future economic value of babies resulting from fertility treatments (ESHRE Capri Workshop Group, 2015).”

    From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as ESHRE Capri Workshop Group, 2015

    The “Full economic analysis of the value of conceiving a child through IVF” section says reimbursing IVF is cost-effective from a macroeconomic perspective and reports an estimated eightfold government return from an ART-conceived child’s future taxes. But the claim extends that conclusion to fertility care generally: the same section notes a population for whom IVF was not cost-effective, and the Conclusions call for better evidence and economic models. Page numbers are not provided in the supplied passages. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
ESHRE Capri Workshop Group, ESHRE Capri Workshop Group, Baird, D. T., Barri, P. N., Bhattacharya, S., Devroey, P., Evers, J. L. H., Gianaroli, L., Somigliana, E., Tapanainen, J. S., van Wely, M., Crosignani, P. G., Diedrich, K., Fraser, L. R., Geraedts, J. P. M., Lundin, K., Sunde, A., Tarlatzis, B., Steirteghem, A. V., Veiga, A., Bhattacharya, S., Crosignani, P. G., Evers, J. L. H., & Somigliana, E.
Venue
Human Reproduction
Published
2015-07-03
Volume
30
Issue
10
Pages
2243-2248
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2228973427
Cited by
89
References
42
Citations by year
2026: 4 · 2025: 8 · 2024: 10 · 2023: 13 · 2022: 9 · 2021: 10 · 2020: 9 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 3
FWCI
7.62
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (publishedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
Institut Biochimique S.A.
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
Keywords
infertility treatment, cost-effectiveness analysis, assisted reproduction, in vitro fertilization, intracytoplasmic sperm injection, unexplained infertility, quality-adjusted life years, health care financing, outcome measures
MeSH terms
Cost-Benefit Analysis, Embryo Transfer, Female, Fertilization in Vitro, Humans, Infant, Newborn, Infertility, Male, Pregnancy, Pregnancy Outcome, Semen, Reproductive Medicine, Models, Economic, Quality-Adjusted Life Years, Sperm Injections, Intracytoplasmic, Reproductive Techniques, Assisted, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review